Review Article
Volume 9 Issue 4 - 2020
Vaccination is an Effective Way to Prevent Viral Diseases? - Proposal for Oral Adjuvant System
Daisuke Sakamoto1Depatment of Cardiovascular Surgery, Kanazawa Medical University, Uchinada, Ishikawa, Japan, Yasuhiro Nagayoshi1, Yuma Katoh2, Nobuo Yamaguchi3* and Shigeru Sakamoto1
1Depatment of Cardiovascular Surgery, Kanazawa Medical University, Uchinada, Ishikawa, JapanDepatment of Cardiovascular Surgery, Kanazawa Medical University, Uchinada, Ishikawa, Japan
2Department of Respiratory Medicine, Tokai Central Hospital, Gifu, Japan
3Ishikawa Natural Medicinal Products Research Center, Foundation, Fukubatake, Kanazawa, Ishikawa Japan
*Corresponding Author: Nobuo Yamaguchi, Department of Immunology, Faculty of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Received: March 05, 2020; Published: March 23, 2020


Background: A newly emerging Corona virus disease is necessary to provide international cooperation to regulate this virus. Extended IRS promised to induce immunological dysfunction with qualitative and quantitative. This disease led to age-related disabilities, but only a small proportion of the persons concerned seek medical attention. To concur the microbial disease, an establishment of vaccine is conventional way for prevention. However, virus diseases are different from microbial one, so the development of vaccine for virus diseases may different from bacterial one. 

Purpose: This report suggested that the establish a better virus vaccine innovates from classic vaccine preparation

Pathology of Viral Disease: Therefore, the viruses are absolutely dependent system for the production of their own species, they hide out in the host cell, such as liver cell by liver virus. Immunological attack of IgG antibodies to infected liver cell, induced hepatitis in the host. In other words, there was no pathogenic anomaly just seclusion by liver virus in liver cell.

Discussion Points for the Development of the Vires Vaccine: A High titer of IgG antibodies may damage the virus-infected host cell. Only secretory IgA with secretory piece in the mucus membrane is effective to prevent virus infection. Immunoglobulin classes are absolutely important for the prevention of viral infections as the first line of defense.


  1. Antibodies against the virus limited to prevent syndrome.
  2. It depend on the immunoglobulin (Ig) class.
  3. Repeated antigen stimulation induce secondary response that mounted by IgG antibodies.
  4. Hemopoietic herbal decoction may play an adjuvant for induce viral vaccine.
  5. Serum IgG attacks virus together with host cell that share the room in the host.
  6. The immunoglobulin class A, IgA, with secretory piece, is the most important for the development of the newly developing viral vaccine.

Keywords: Viral Disease; Vaccine; COVID-19; Oral Adjuvant; Immunoglobulin Class; IgA; IgM; IgG; Secretory IgA


  1. Zhe X., et al. “Pathological findings of COVID-19 associated with acute respiratory distress syndrome”. Lancet Respiratory Medicine (2020). 
  2. Yongyan Chen and Zhigang Tian. “VIRAL-Induced Immune Imbalance in the Development of HCC”. Frontiers in Immunology 10 (2019): 2048.
  3. Kaiyuan S., et al. “Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population level observational study”. Lancet (2020).
  4. Catherine C., et al. “Comparison of the implementation of human papillomavirus and hepatitis B vaccination programs in the United States: Implications for future vaccines”. Vaccine 38.5 (2020): 954-962.
  5. Xiaobo Y., et al. “Coarse and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study”. Lancet Respiratory Medicine (2020).
  6. Huijun C., et al. “Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical record”. Lancet 395.10226 (2020): 809-815.
  7. Yamaguchi N., et al. “Aspect of QOL Assessment and Proposed New Scale for Evaluation”. Open Journal of Immunology 5.3 (2015): 147-182. 
  8. Yamaguchi N and Izumi H. “A Constitution Dependent Digital QOL Assessment”. EC Gynaecology 8.5 (2019): 344-352. 
  9. Kurashige S., et al. “Immune response in Sarcoma10-bearing mice”. Annual Reports Gunnma University 1 (1980): 36-44. 
  10. Kishida K., et al. “Cranial irradiation and lymphocyte subpopulation in acute lymphatic leukemia”. Journal of Pediatrics 92.5 (1978): 785-786.
  11. Yamaguchi N., et al. “Maternal Bias of Immunity to Her Offspring: Possibility of an Autoimmunity Twist out from Maternal Immunity to Her Young”. Open Journal of Rheumatology and Autoimmune Diseases 3.1 (2013): 40-55.
  12. Murgita RA and Tomasi Jr TB. “Suppression of the Immune Response by alpha-Fetoprotein”. The Journal of Experimental Medicine 141.2 (1975): 269-286. 
  13. Paul G., et al. “Helper+ but Not Cytotoxic+ T Cells are Required for the Induction of Oral Tolerance”. International Immunology 7.3 (1995): 501-504. 
  14. Koshimo H., et al. “Maternal Antigenic Stimulation Actively Produces Suppressor Activity in Offspring”. Developmental and Comparative Immunology 13.1 (1989): 79-85. 
  15. Zoeller M. “Tolerization during Pregnancy: Impact on the Development of Antigen-Specific Help and Suppression”. European Journal of Immunology 18.12 (1988): 1937-1943. 
  16. Auerback R and Clark S. “Immunological Tolerance: Transmission from Mother to Offspring”. Science 189.4205 (1974): 811-813. 
  17. Shinka S., et al. “Immunological Unresponsiveness in Mice. I. Immunological Unresponsiveness Induced in Embryonic Mice by Maternofetal Transfer of Human-Globulin”. Biken Journal 17.2 (1974): 59-72. 
  18. Aase J M., et al. “Mumps-Virus Infection in Pregnant Women and the Immunologic Response of Their Offspring”. The New England Journal of Medicine 286.26 (1972): 1379-1382. 
  19. Cramer DV., et al. “Immunologic Sensitization Prior to Birth”. American Journal of Obstetrics and Gynecology 120.3 (1974): 431-439. 
  20. Wang XX., et al. “Variation of Cell Populations Taking Charge of Immunity in Human Peripheral Blood Following Hot Spring Hydrotherapy Quantitative Discussion”. The Journal of Japanese Association of Physical Medicine, Balneology and Climatology 62 (1999): 129-134.
  21. Matsuno H., et al. “Variation of Cell Populations Taking Charge of Immunity in Human Peripheral Blood Following Hot Spring Hydrotherapy Qualitative Discussion”. The Journal of Japanese Association of Physical Medicine, Balneology and Climatology 62 (1999): 135-140.
  22. Yamaguchi N., et al. “Effect of Acupuncture on Leukocyte and Lymphocyte Subpopulation in Human Peripheral Blood-Quantitative discussion”. The Journal of Japanese Association of Physical Medicine, Balneology and Climatology 65.4 (2002): 199-206.
  23. Wan W., et al. “Effect of Acupuncture on Leukocyte and Lymphocyte Subpopulation in Human Peripheral Blood Qualitative discussion”. The Journal of Japanese Association of Physical Medicine, Balneology and Climatology 65.4 (2002): 207-211.
  24. Wang XX., et al. “Effect of physical exercise on leukocyte and lymphocyte subpopulations in human peripheral blood”. Cyto Research 8 (1998): 53-61.
  25. Kitada Y., et al. “Regulation of peripheral white blood cells in numbers and functions through hot-spring bathing during a short term - studies in control experiments”. Journal of Japanese Society Balneology Climatology Physiological Medicine 63.3 (2000): 151-164.
  26. Yamaguchi N., et al. “Acupuncture Regulates Leukocyte Subpopulations in Human Peripheral Blood”. Evidence-Based Complementary and Alternative Medicine 4.4 (2007): 447-453.
  27. Yamaguchi N., et al. “Hydrotherapy can Modulate Peripheral Leukocytes: An Approach to Alternative Medicine”. An Approach to Alternative Medicine Complementary and Alternative Approaches to Biomedicine (Edwin L. Cooper, Nobuo Yamaguchi), Kluwer Academic/ Plenum Publishers, New York (2004): 239-251.
  28. Ostberg JR., et al. “Regulation of immune activity by mild(fever-range) whole body hyperthermia: effect on epidermal Langerhans cells”. Cell Stress Chaperones 5.5 (2000): 458-461.
  29. Huang YH., et al. “Effect of in vitro hyperthermia on proliferative responses and lymphocyte activity”. Clinical Experimental Immunology 103.1 (1996): 61-66.
  30. Bicknell PG. “Sensorineural deafness following myringoplasty operations”. Journal of Laryngology and Otology 85.9 (1971): 957-961.
  31. Schwetz F. “Das Absinken der Horkurve in hoheren Frequenzbereich nach Stapesplastik”. Archiv für Ohren-, Nasen- und Kehlkopfheilkunde 179 (1962): 545-549.
  32. Mats H., et al. “Balneotherapy in Dermatology”. Dermatological Therapy 16.2 (2003): 132-140.
  33. Elenkov IJ and Chrousos GP. “Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease”. Trends in Endocrinology and Metabolism 10.9 (1999): 359-368.
  34. Abo T and Kumagai K. “Studies of surface immunoglobulins on human B lymphocytes. Ⅲ. Physiological variations of Sig+ cells in peripheral blood”. Clinical Experimental Immunology 33.3 (1978): 441-452.
  35. Abo T. “Studies on the bioperiodicity of the immune response. 1. Circadian rhythms of human T, B and K cell traffic in the peripheral blood”. Journal of Immunology 126.4 (1981): 1360-1363.
  36. Suzuki S., et al. “Circadian rhythm of leukocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system”. Clinical Experimental Immunology 110.3 (1997): 500-508.
  37. Hamada M and Yamaguchi N. “Effect of Kanpo Medicine, Zyuzentaihoto, on the Immune Reactivity of Tumor-Bearing Mice”. Journal of Ethnopharmacology 24.2-3 (1988): 311-320.
  38. Tu CC., et al. “Comparative Use of Biomedicine and Chinese Medicine in Taiwan: Using the NHI Research Database”. Journal of Alternative and Complementary Medicine 17.4 (2011): 339-346.
  39. Lin YH and Chiu JH. “Use of Chinese Medicine by Women with Breast Cancer: A Nationwide Cross-Sectional Study in Taiwan”. Complementary Therapies in Medicine 19.3 (2011): 137-143.
  40. Yamaguchi N., et al. “Bi-Directional Regulation by Chinese Herbal Formulae to Host and Parasite for Multi-Drug Resistant Staphylococcus aureus in Humans and Rodents”. Open Journal of Immunology 5 (2015): 18-32.
  41. Yamaguchi N., et al. “Hemopoietic Formulae Rearranged Leukocyte Subsets and Implication for Use against the Type of Constitution and Infectious Agent for Further Modification to Future”. Open Journal of Immunology 5 (2015): 183-198. 
Citation: Nobuo Yamaguchi., et al. “Vaccination is an Effective Way to Prevent Viral Diseases? - Proposal for Oral Adjuvant System”. EC Paediatrics 9.4 (2020): 94-102.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 03, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.